We examined sequencing data from publicly available datasets and published literature, and identified an additional 75 tumor samples and two thyroid cancer cell lines with KEAP1 mutations (Figure 1, Supplementary Table S2). The gene discussed is KEAP1; the disease is thyroid gland carcinoma.